chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is the email from the patient: I did want to follow up and let you know that I think I had a reaction to my tetanus shot the evening after. I am assuming that, but it seemed to fit. Thursday evening I was in store around 8PM and started feeling a tingling in my thumbs and wrist - kind of like a sensitivity when you have a fever. It started in just my right, but then was in my left as well. I felt fine, but was starting to get a little headache (which I rarely get headaches). I went home and went to bed around 9:30. I fell asleep fine, but woke up around midnight with terrible body aches, fierce headache and sweating. I didn't really want to move to get up at all because my body just ached and hurt so bad. But I did get up to check my temperature and it was 103.1 with my in ear electronic thermometer. Even in my messed up state I thought that was crazy, so I tried my older in the mouth digital read out, and that one came up as 102.9. I took some Tylenol and crawled back in bed. Could not sleep much - somewhat just uncomfortable - freezing but sweating, somewhat a bit concerned about the fever temp. After on and off naps and restlessness for a 2.5 hour time span, I took my temp again - 102.1. Contemplated if I needed to go in to ER, but figured it was coming down and I wasn't about to call for transport and I wasn't about to drive. So, I took and 3 ibuprofen, changed into dry pajamas and again tried to sleep. Tossed and turned for another couple of uncomfortable hours, checking my temp every so often. By around 8:00 AM it was down to 101.3  and lingered around 100.5 most of the day and evening Friday, ranging down to 99.5. I called into work Friday (which is another extremely rare doing), but I was exhausted. It felt like a very violent night. I slept fine Friday night and when I woke up on Saturday, I felt fine - temp 99.1. So, all is well now, just thought I should let you know. I have never had a reaction to a tetanus shot before, but that was my Google educated guess. My arm from the shot also was almost like a hard spot of about 3 inches in diameter where the shot was until it started lessening on Saturday - I iced it a few times. My arm was also very sore until about Monday sometime, which is longer than ever before as well. I didn't have a good feeling when it bled as much as it did when she gave me the shot, but I am sure that happens, it just has never to me quite like that before. Anyway, just thought I should tell you.
Information has been received from a Registered Nurse (also reported as a nurse practitioner) concerning a current 19 year old male patient who when he was approximately 4 year old, on 13-OCT-1995 was vaccinated with a first dose of RECOMBIVAX HB (route and lot number unspecified). After the first injection the mother contacted the physician and she reported that she noted a large erythematous area in child's arm. On 27-NOV-1995, the patient was vaccinated with a second dose of RECOMBIVAX HB (route, lot number and expiration date not provided). And the mother reported to the physician that immediately after receiving the vaccine the child experienced difficulty breathing, he was coughing and wheezing. The patient had a temperature for four days and a large erythematous area on his arm that was larger than the one she noted on 13-OCT-1995. The patient contacted the physician. When the patient was seen at the physician's office the child had recovered. Follow-up information has been received from an office manager who reported that she had not had an adverse event associated with any of her patients at her office. Additional information is not expected.
Vaxelis vaccine given accidentally instead of Dtap vaccine. Pt parent informed of error. Pt is doing well. No adverse reactions as of yet.
Covid19 breakthrough.  Vaccinated on 3/25/2021.  66 y/o PMH ESRD on HD, HTN, COPD, Type 2DM, Prostate CA, CHF presents to ED with c/o progressive SOB and weakness x2 days.  Pt states tested + for Covid at home and therefore missed 2 dialysis treatments this week. CXR with mild failure, pt on O2 2L NC, afebrile.  Pt treated with steroids and Remdesivir.
This spontaneous report as received from a nurse refers to roughly 20 unspecified patients of unknown age. On an unknown date, roughly 20 unspecified were vaccinated with VARIVAX (Merck) Injection, (strength, dose, frequency, route of administration and indication were not provided) that reached 18.5 F for 10 hours and 44 minutes. This range was outside of storage conditions in product insert; however, in house stability data can support those conditions mentioned above that the VARIVAX (Merck) was exposed to. No concomitant medication was reported. No adverse effects reported. No product quality complaint (PQC) was reported. The outcome of events was unknown. No further adverse event information was available. Follow up information (after previous telephone attempt to obtain follow up information which has been unsuccessful) has been received from a nurse concerning VARIVAX (Merck) temperature excursion and one patient of unspecified age and gender who was vaccinated with VARIVAX (Merck) (injection, strength, dose, frequency, route of administration and indication were not provided) (lot # J012211, exp date: 28-SEP-2015) that reached 18.5 F for 10 hours and 44 minutes. This is one of several reports received from the same source. Additional information has been requested.
Consistent headache after waking up the day after vaccine. Body aches and weakness last for 8 hours
Itchy Sensation in Testicles; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy Sensation in Testicles) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PRURITUS (Itchy Sensation in Testicles). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Itchy, at a dose of 1 dosage form. At the time of the report, PRURITUS (Itchy Sensation in Testicles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reported. Treatment included Dermatology cream.
C/o mild soreness to injection site (Lt Del) on lifting arm. No swelling, increased warmth, redness, sensitivity to touch or fever.
Vertigo; worsened balance; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), BALANCE DISORDER (worsened balance) and FATIGUE (fatigue) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included OCRELIZUMAB (OCREVUS) for an unknown indication.   On 29-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (Vertigo), BALANCE DISORDER (worsened balance) and FATIGUE (fatigue). At the time of the report, VERTIGO (Vertigo), BALANCE DISORDER (worsened balance) and FATIGUE (fatigue) had not resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Treatment to the events not provided.
06/04/04: 5:00 Am 104 degrees fever chills. 06/04/04: 4:30 pm 104.5 fever. 06/04/2004- 06/07/2004: 104 fever three days.
After a month has passed since vaccination, patient states he still has a bump (small pimple like or mosquito bite) at the site of injection.
Information has been received from a physician concerning a 12-15 year old (exact age unknown) female patient who in April 2007, was vaccinated with a dose of Gardasil. The patient started to convulse in front of the physician and her eyes rolled back after receiving the Gardasil. The patient received medical attention. The physician's office followed up with the patient the next day and she was doing fine. Upon internal review, convulsion was considered to be an other important medical event. The physician reported that another patient in the same age group convulsed after receiving the Gardasil. Additional information has been requested.
The patient developed symptoms on 25Dec2020, tested positive on 31Dec2020; She was supposed to receive second vaccine on 06Jan2021, but put it off; The patient developed symptoms on 25Dec2020, tested positive on 31Dec2020; This is a spontaneous report from a other HCP. A female patient (Age: 45, Unit: Unknown) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on 16Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient developed symptoms on 25Dec2020, tested positive on 31Dec2020. She was supposed to receive second vaccine on 06Jan2021, but put it off because she was told by Pfizer she had to wait 90 days. She was calling for guidance because her hospital was telling her she was eligible to receive the vaccine. She already filed a report with safety when she initially developed symptoms that included loss of smell, taste and headaches. The outcome of the event was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162B2 in this patient cannot be completely excluded.
Information has been received from a pharmacist concerning a 30 years old female - another pharmacist, who is currently lactating and was preparing to administer a dose of ZOSTAVAX (lot # not reported) to a patient on 11-SEP-2012 (today), when she accidentally pricked her finger with the administration needle. She immediately washed her finger with the needle puncture would on it. She had not sought medical attention at the moment, because the incident had occurred 20 minutes prior to the time of reporting. The patient for which the dose of ZOSTAVAX was intended did not miss a dose because another dose of ZOSTAVAX was prepared for the patient and administered at that time. Additional information has been requested.
fever; headache; Swelling at the injection site; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 53-year-old female patient who received Herpes zoster (Shingrix) (batch number BP57E, expiry date 7th December 2021) for prophylaxis.   On 10th October 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced fever, headache and injection site swelling. On an unknown date, the outcome of the fever, headache and injection site swelling were resolved with sequelae.   It was unknown if the reporter considered the fever, headache and injection site swelling to be related to Shingrix.  Additional details were reported as follows: The patient experienced fever, headache and swelling at the injection site. The symptoms lasted a few days after the 1st shot. The reporter consented to follow up. For tolerence to the 2nd dose, refer case US2020014933.
HEADACHE, NAUSEA, 100 DEGREE FEVER THE FOLLOWING DAY.
felt tiredness after each of his Moderna COVID-19 vaccinations.; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (felt tiredness after each of his Moderna COVID-19 vaccinations.) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced FATIGUE (felt tiredness after each of his Moderna COVID-19 vaccinations.). At the time of the report, FATIGUE (felt tiredness after each of his Moderna COVID-19 vaccinations.) outcome was unknown.            No concomitant medication was reported.  The patient did not report any other adverse events.  No treatment information was provided.   This case was linked to MOD-2022-554801 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2022: Live follow up received includes non significant information.
The patient started to see a rash and some swelling on Sunday 08/15 in the morning about 7 days after the vaccine, reported the reaction, reports today that the reaction swelling has decreased as well as the redness in color but the size has increased a little.
On 8/21/01, Tuesday night, pt started bruising of left deltoid and redness. By 8/22/01, Wednesday, site was red, swollen and tender with complaint of discomfort at side and client is not wanting to use left arm. Thursday assessment of left arm; redness of deltoid measuring about 50cm X 70cm. Mother of client had treated with po Tylenol with good results of decreasing discomfort at site but it is now itching and warm to touch.
This case was reported by a nurse via call center representative and described the occurrence of shingles in a 60-year-old female patient who received SHINGRIX (batch number 3S354, expiry date 4th July 2020). On 1st March 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 2nd March 2018, 1 days after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. The reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follows: The case was reported by the nurse who administered the vaccine to the patient. This case was previously not reported to anyone. The patient called to report that they were diagnosed with shingles on 2nd March 2018. The caller was transferred to medical information for discussion.
Left arms swollen and painful to touch. Headaches and very painful body aches and muscle aches. Occurrences started 01/06/2021 at approximately 5:30 am.
Left arm very tender, red, and hot.  All over feeling of soreness and exhaustion, dizziness.  Eyes very irratated and tender.  Had to lay down and rest.
breathing labored while walking or doing activity; swollen lymph nodes/ lymph nodes were enlarged slightly; fluid built up around heart and lungs; fluid built up around heart and lungs; white blood count was elevated; heart was weak and only working at 29% percent; heart was weak and only working at 29% percent; This is a spontaneous report received from a contactable consumer (patient). A non-pregnant 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 13Feb2021 at 18:00 (at the age of 43 years old) (Lot Number: EM9809, unknown expiration) as 2nd dose, single for COVID-19 immunization.  Medical history included penicillin allergy.  There were no concomitant medications.  The patient also received first dose of BNT162B2 on 23Jan2021 at 18:00 (at the age of 43 years old) (lot number: EL3247, unknown expiration) in left arm for COVID-19 immunization. After the second shot, the patient did notice swollen lymph nodes on 02Apr2021 for several days.  She noticed her breathing labored while walking or doing activity on 02Apr2021 after getting the second shot. In 8 weeks, the patient went to the ER and found that she had fluid built up around heart and lungs which started on 02Apr2021.  They also found in a CT scan that lymph nodes were enlarged slightly and that the patient's white blood count was elevated on 02Apr2021. After an echocardiogram on 02Apr2021, they determined that the patient's heart was weak and only working at 29% percent.  The patient has had no prior history of heart problems or was taking any medications. The patient was given many heart medications to strengthen the heart and treatment for the events. The events resulted in emergency room/department or urgent care visit. The patient has no COVID and was not diagnosed with COVID prior to vaccination. The patient was tested for COVID via nasal swab on 10Apr2021 with negative result. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Outcome of the events was unknown. The events were assessed as serious (hospitalization) for 8 days.   No follow-up attempts are needed. No further information is expected.
I had no real adverse event.  I was Rx'd Paxlovid because of my age.  My symptoms were extremely mild, mostly just hoarse, and I had rebound of the same mild symptom.
h/a 25AUG-28AUG-29AUG; upset stomach 26AUG-28AUG; fever 103.4; vomiting 27AUG x 1; stiff, dizzy 27AUG;
Fever 104, chills, nauseas, swollen lymph's armpits, severe headaches
pt recvd vax in afternoon been in ER that PM secondary to choking episode followed by dec responsiveness, ashen color; In ER pt noted to be pale w/dec activity;
Bumps started popping up on 04/12/2005 stated mother and kept spreading worse.
This spontaneous report as received from a Nurse Practitioner refers to a female patient of unknown age. The patient's concurrent conditions included diabetes. On unspecified dates, the patient received 2 separate series of RECOMBIVAX HB (Lot # Not provided), the 1st series "as a child" and the 2nd series on unspecified dates, as required for medical school. The Nurse practitioner reported that an unspecified primary care provider tested the patients for titers after each series of RECOMBIVAX HB, all on unspecified dates. The patient had always tested negative for titers after vaccination with RECOMBIVAX HB. Titers were taken on an unspecified dates. Patient's outcome was unknown. Same patient link 1309USA010446. Additional information has been requested.
10 pts experienced inject site rxn immediately following immun; knot @  inject site, burning pain & inability to move arm for 10min; pt immun fr same vial;
Within the hour of receiving her 2 month shots my child was inconsolable. I had been warned about being over tired and a slight fever. But I was not prepared for days of fevers, and my child being unable to sleep for more then 20 minutes at a time. When her fever finally cleared she had a weird catch in her breathing. Her pediatrician said it was normal. On 12/16/2015 she stopped breathing in her sleep. I struggled to wake her up. We rushed to the ER. Once awake she seemed fine. We followed up with our pediatrician, who ordered an EEG and put her on reflux medication, though she had no signs of reflux. She also referred us to a pulmonologist. We discovered after a sleep study that she had severe sleep apnea, which she hadn't had during her time in the NICU, as she was born 5 weeks early and was in the NICU for 5 days. She had more episodes where she stopped breathing and I struggled to wake her up, and then they faded and she seemed to be ok. We got the 4 month shots on time and the same thing happened, but the breathing episodes in her sleep were much more frequent- several times a week. Enough time passed after the vaccines that by the time we had our second sleep study that we had begun some holistic detoxing and when we got the test done her sleep study results were normal. Her pulmonologist was shocked that her apnea had cleared up like that.
Information has been received from a registered nurse referring to unspecified number of patients of unknown age and gender. There was no medical history or concurrent condition reported. On unknown dates since 25-SEP-2015, the unspecified patients were vaccinated with doses of improperly stored VARIVAX (Merck) (lot # L013827, expiration date 21-APR-20160 (dosage, strength and route were not reported). There was no concomitant medication reported. No adverse effect was reported. This is one of several reports from the same reporter. Additional information has been requested.
A patient is here today to get  2nd dose, 60 days after getting  his 1st dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (A patient is here today to get  2nd dose, 60 days after getting  his 1st dose) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (A patient is here today to get  2nd dose, 60 days after getting  his 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (A patient is here today to get  2nd dose, 60 days after getting  his 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Next day, shingles on the right side of my body. It started middle of stomach and went around to my back. Four or five spots - red and irritated and itched like crazy. This was only one line (have had shingles before and they were all over but this was just one line). Middle between beltline and shoulders. I got on some medication from the doctor for a  few days - to ease the symptoms of the shingles. It seemed like a mild case. A couple of the spots got real sort of puffy like but they weren't too bad.  It lasted about two weeks.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose12/20/21 2nd dose01/10/21 Diagnosed covid positive:09/15/21 Symptom onset:09/14/21 Exposure:community Symptoms:loss of smell/taste,sore throat,runny nose
Patient received vaccine and was waiting for 30 minutes in the observation area due to history of allergic reactions. At 20-minutes post-vaccination, patient experienced hives and swelling in her tongue. Patient reported to EMS that it felt like previous allergic reactions. EMS assessed VS. BP 151/101, HR 98, O2 sat 97%. EMS administered 1 Epi pen into the R thigh. Patient had a rapid resolution of symptoms. EMS recommended transport to ER, patient agreed. Transported to EMS. Post epi vitals were 150/69, HR 80, O2 Sat 97%.
Has very low appetite; Extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Has very low appetite) and FATIGUE (Extremely tired) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced DECREASED APPETITE (Has very low appetite) and FATIGUE (Extremely tired). On 20-Feb-2021, DECREASED APPETITE (Has very low appetite) and FATIGUE (Extremely tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Additional info: TCR : updated events outcome from unknown to recovered.